File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Squamous cell carcinoma of the esophagus with mucin-secreting component: Mucoepidermoid carcinoma

TitleSquamous cell carcinoma of the esophagus with mucin-secreting component: Mucoepidermoid carcinoma
Authors
Issue Date1994
PublisherMosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/jtcvs
Citation
Journal Of Thoracic And Cardiovascular Surgery, 1994, v. 107 n. 1, p. 62-67 How to Cite?
AbstractAmong 1058 patients with cancer of the esophagus, 20 patients with mucoepidermoid or adenosquamous cell carcinoma of the esophagus and cardia, together defined as squamous cell carcinoma with a mucin-secreting component, were seen over a 10-year period. Their records were reviewed and appropriate comparisons were also made with the more common squamous cell carcinomas and adenocarcinomas. Squamous cell carcinoma with mucin-secreting component comprised 1.9% of all tumors encountered. Clinical features including age, male predominance, symptoms at presentation, length of tumor, and appearance of tumor did not differ from those of squamous cell and adenocarcinoma. The location of these tumors, however, followed that of squamous cell carcinomas, with 55% in the middle third and 25% in the lower third. Adenocarcinomas were found predominantly at the cardia (83%). Operability and resectability rates were higher than those of squamous cell and adenocarcinomas. Primary treatment consisted of resection in 19 of the 20 patients (95%); 18 of them had a one-stage resection and 1 patient had a two-stage resection. Postresection staging showed that 5% had stage I disease, 16% had stage II, and 79% had stage III disease. None of the patients who underwent resection died within 30 days of the operation. The mortality after 30 days was 10.5%. The 1 patient in whom intubation was the primary treatment had distant metastases at the time of presentation (stage IV). The overall median survival was 9.2 months. The median survival for patients who had their tumors resected was 9.5 months. The survival improved to 33 months for curative resection but was only 8.7 months for palliative resection. The 1-, 2-, and 5-year survivals were 46%, 39%, and 0%, respectively. This prognosis was not significantly different from that of patients with squamous cell carcinoma or adenocarcinoma.
Persistent Identifierhttp://hdl.handle.net/10722/84420
ISSN
2015 Impact Factor: 3.494
2015 SCImago Journal Rankings: 2.369
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorFegelman, Een_HK
dc.contributor.authorLaw, SYKen_HK
dc.contributor.authorFok, Men_HK
dc.contributor.authorLam, KYen_HK
dc.contributor.authorLoke, SLen_HK
dc.contributor.authorMa, LTen_HK
dc.contributor.authorWong, Jen_HK
dc.date.accessioned2010-09-06T08:52:45Z-
dc.date.available2010-09-06T08:52:45Z-
dc.date.issued1994en_HK
dc.identifier.citationJournal Of Thoracic And Cardiovascular Surgery, 1994, v. 107 n. 1, p. 62-67en_HK
dc.identifier.issn0022-5223en_HK
dc.identifier.urihttp://hdl.handle.net/10722/84420-
dc.description.abstractAmong 1058 patients with cancer of the esophagus, 20 patients with mucoepidermoid or adenosquamous cell carcinoma of the esophagus and cardia, together defined as squamous cell carcinoma with a mucin-secreting component, were seen over a 10-year period. Their records were reviewed and appropriate comparisons were also made with the more common squamous cell carcinomas and adenocarcinomas. Squamous cell carcinoma with mucin-secreting component comprised 1.9% of all tumors encountered. Clinical features including age, male predominance, symptoms at presentation, length of tumor, and appearance of tumor did not differ from those of squamous cell and adenocarcinoma. The location of these tumors, however, followed that of squamous cell carcinomas, with 55% in the middle third and 25% in the lower third. Adenocarcinomas were found predominantly at the cardia (83%). Operability and resectability rates were higher than those of squamous cell and adenocarcinomas. Primary treatment consisted of resection in 19 of the 20 patients (95%); 18 of them had a one-stage resection and 1 patient had a two-stage resection. Postresection staging showed that 5% had stage I disease, 16% had stage II, and 79% had stage III disease. None of the patients who underwent resection died within 30 days of the operation. The mortality after 30 days was 10.5%. The 1 patient in whom intubation was the primary treatment had distant metastases at the time of presentation (stage IV). The overall median survival was 9.2 months. The median survival for patients who had their tumors resected was 9.5 months. The survival improved to 33 months for curative resection but was only 8.7 months for palliative resection. The 1-, 2-, and 5-year survivals were 46%, 39%, and 0%, respectively. This prognosis was not significantly different from that of patients with squamous cell carcinoma or adenocarcinoma.en_HK
dc.languageengen_HK
dc.publisherMosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/jtcvsen_HK
dc.relation.ispartofJournal of Thoracic and Cardiovascular Surgeryen_HK
dc.rightsThe Journal of Thoracic and Cardiovascular Surgery. Copyright © Mosby, Inc.en_HK
dc.titleSquamous cell carcinoma of the esophagus with mucin-secreting component: Mucoepidermoid carcinomaen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0022-5223&volume=107&spage=62&epage=67&date=1994&atitle=Squamous+cell+carcinoma+of+the+esophagus+with+mucin-secreting+component:+mucoepidermoid+carcinomaen_HK
dc.identifier.emailLaw, SYK: slaw@hku.hken_HK
dc.identifier.emailWong, J: jwong@hkucc.hku.hken_HK
dc.identifier.authorityLaw, SYK=rp00437en_HK
dc.identifier.authorityWong, J=rp00322en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.pmid8283920-
dc.identifier.scopuseid_2-s2.0-0027954934en_HK
dc.identifier.hkuros3770en_HK
dc.identifier.volume107en_HK
dc.identifier.issue1en_HK
dc.identifier.spage62en_HK
dc.identifier.epage67en_HK
dc.identifier.isiWOS:A1994MR27500011-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridFegelman, E=6507214463en_HK
dc.identifier.scopusauthoridLaw, SYK=7202241293en_HK
dc.identifier.scopusauthoridFok, M=7005879262en_HK
dc.identifier.scopusauthoridLam, KY=7403657165en_HK
dc.identifier.scopusauthoridLoke, SL=7006559512en_HK
dc.identifier.scopusauthoridMa, LT=7403574642en_HK
dc.identifier.scopusauthoridWong, J=8049324500en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats